Application 761088

Type
BLA
Sponsor
CELLTRION INC

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761088Truximarituximab-abbs351(k) BiosimilarRx2026-06-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TRUXIMARITUXIMAB-ABBSINJECTABLE;INJECTION100MG/10ML(10MG/ML)NoNo
002TRUXIMARITUXIMAB-ABBSINJECTABLE;INJECTION500MG/50ML(10MG/ML)NoNo

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TruximaRITUXIMAB-ABBSCephalon, Inc.9af3ddc7-4217-417a-ac89-8704edc5bc442026-07-13Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA761088
ndc (product): 63459-104
ndc (product): 63459-103

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 16 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
63459-103Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-103Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-103Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-103Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-103Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-103Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-103Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-103Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-104Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-104Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-104Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-104Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-104Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-104Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-104Truximarituximab-abbsCephalon, Inc.BLACurrent
63459-104Truximarituximab-abbsCephalon, Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83235SUPPL 2025-08-29
82512SUPPL 2025-06-10
70122SUPPL2022-02-08
70121SUPPL2022-02-08
70113SUPPL2022-02-08
63394SUPPL2020-06-02
63393SUPPL2020-06-02
63389SUPPL2020-06-02
61404SUPPL2019-12-23
61403SUPPL2019-12-23
61357SUPPL2019-12-19
61356SUPPL2019-12-19
61355SUPPL2019-12-19
61354SUPPL2019-12-19
58858SUPPL2019-05-31
58857SUPPL2019-05-31
58849SUPPL2019-05-31
58848SUPPL2019-05-31
58847SUPPL2019-05-31
58846SUPPL2019-05-31
57811ORIG2019-02-26
57808ORIG2019-02-25
56580ORIG2018-11-28